TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
URGN

UroGen Pharma Ltd

Healthcare · Biotechnology

43.30$ -1.6% vs. previous close Closing price · As of: Sep 18, 2026

Investor relations

Report Dates

Investor relations overview for UroGen Pharma Ltd (URGN): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 11/05/2026.

Next report 11/05/2026
Last report 08/05/2026
Earnings surprise by quarter (%)
Q3 23 · 21.8 % 23 Q4 23 · -5.9 % 23 Q1 24 · -11.5 % 24 Q2 24 · -9.6 % 24 Q3 24 · 32.9 % 24 Q4 24 · -11.1 % 24 Q1 25 · -16.5 % 25 Q2 25 · -28.1 % 25 Q3 25 · -1.5 % 25 Q4 25 · -9.9 % 25 Q1 26 · 2.1 % 26 Q2 26 · 26.3 % 26

EPS estimate beaten

Full history 14 of 37 quarters (38%)
Last 16 quarters 6 of 16 quarters (38%)

Earnings Call Transcripts

Search all transcripts →

  • 08/05/2026 Earnings Call Q2 2026 Open →
  • 05/06/2026 Earnings Call Q1 2026 Open →
  • 03/02/2026 Earnings Call Q4 2025 Open →
  • 11/06/2025 Earnings Call Q3 2025 Open →
  • 08/09/2025 Earnings Call Q2 2025 Open →
  • 05/12/2025 Earnings Call Q1 2025 Open →
  • 03/10/2025 Earnings Call Q4 2024 Open →
  • 11/06/2024 Earnings Call Q3 2024 Open →
  • 08/13/2024 Earnings Call Q2 2024 Open →
  • 05/13/2024 Earnings Call Q1 2024 Open →

News on This Stock

  • 08/20/2026 UroGen Pharma Ltd. (URGN): Other Events · sec.gov Open ↗
  • 08/05/2026 UroGen Pharma Ltd. (URGN): Results of Operations and Financial Condition; Financial Statements and Exhibits · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?